First Edition: Monday, Dec. 1, 2025
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
1,881-1,900 of 113,161 results
Today's early morning highlights from the major news organizations.
The bill from Rep. Robin Kelly, a Democrat from Illinois, would require clinical justification for discharging patients presenting with signs or symptoms of labor, an assessment of travel distance, a confirmed back-up hospital or birthing facility, verification that patients have reliable transportation, and documentation of patient understanding, Becker's Hospital Review reported.
CMS may nix a dozen Medicare Advantage and Part D measures that focus on operational performance or completion of administrative processes. Other health industry news is on Humana's plan to appeal a court loss over the Medicare Advantage star ratings, Asheville's Mission Hospital is removed from immediate jeopardy by CMS, and more.
Of the three infant fatalities, none of the babies or their mothers had been vaccinated against the highly contagious whooping cough. Kentucky has reported 566 confirmed cases of pertussis this year, which is the largest outbreak since 2012. Also: norovirus, measles, RSV, flu, and covid.
“Some kind of an extension may be necessary to get something else done," President Donald Trump said Tuesday. But he added: “Somebody said I wanna extend them for two years. I don’t want to extend them for two years. I’d rather not extend them at all."
Editorial writers examine these public health topics.
The Centers for Disease Control and Prevention's internal database lists Dr. Ralph Abraham, 71, as its principal deputy director, with a start date of Nov. 23, The New York Times reported. Abraham is also the former surgeon general of Louisiana and halted the state health department’s mass vaccination campaigns.
Some prescription cancer drugs are also included in the negotiations. The announcement followed the second round of talks with pharmaceutical manufacturers under a new system implemented by the Biden administration as part of the 2022 Inflation Reduction Act, The Washington Post reported.
Today's early morning highlights from the major news organizations. Note to readers: The First Edition will not be published Thursday or Friday. Look for it again in your inbox on Monday, Dec. 1. Wishing you all a happy Thanksgiving!
Opinion writers tackle these public health topics.
Separately, Novo Nordisk's semaglutide did not slow the progression of Alzheimer's disease more than a placebo, even though some disease-related biomarkers did show some improvement. Also: GLP-1s are being marketed to the non-obese; pregnancy risks from GLP-1s; and more.
The clawback originally was set to go into effect in 2026. However, Stat says, Medicare will move forward with surveys that will pinpoint how much drugs cost for hospitals — surveys that hospitals have managed to push off for 20 years.
Also in the news: the spread of measles, covid, flu, RSV, CWD, and more.
Food banks and pantries across the country predict the increase in demand will continue through December. Other states making news: Missouri, North Carolina, Colorado, Florida, Minnesota, and Maryland.
Thomas Nagy Jr., deputy assistant secretary for human resources at the Department of Health and Human Services, wrote in a federal court filing Friday that all 954 employees who received layoff notices were emailed Nov. 17 and told to return to work, The Hill reported.
Republicans were blindsided over news media reports that the plan would extend Obamacare subsidies, Axios reported. Meanwhile, more Americans say they will go without health insurance if subsidies aren't renewed.
Today's early morning highlights from the major news organizations.
Editorial writers tackle these public health topics.
The resident of Washington state was an older adult with underlying conditions, The Washington Post reported, and was infected with the H5N5 strain. State health officials said the risk to the public is low. Other health news is on lung cancer screening, female crash-test dummy standards, and more.
The company's blockbuster GLP-1 weight loss drugs Zepbound and Mounjaro are slated to be the top-selling drugs in the world this year. Meanwhile, Bayer began to see positive results from its experimental stroke-prevention drug, asundexian, in a late-stage study.
© 2026 KFF